0001209191-20-061502.txt : 20201203
0001209191-20-061502.hdr.sgml : 20201203
20201203163419
ACCESSION NUMBER: 0001209191-20-061502
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201203
FILED AS OF DATE: 20201203
DATE AS OF CHANGE: 20201203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shepard Jay
CENTRAL INDEX KEY: 0001587788
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34620
FILM NUMBER: 201367338
MAIL ADDRESS:
STREET 1: 15977 GRANDVIEW AVENUE
CITY: MONTE SERENO
STATE: CA
ZIP: 95030
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IRONWOOD PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001446847
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043404176
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
BUSINESS PHONE: 617-621-7722
MAIL ADDRESS:
STREET 1: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-03
0
0001446847
IRONWOOD PHARMACEUTICALS INC
IRWD
0001587788
Shepard Jay
C/O IRONWOOD PHARMACEUTICALS, INC.
100 SUMMER STREET, SUITE 2300
BOSTON
MA
02110
1
0
0
0
Class A Common Stock
2020-12-03
4
A
0
24727
0.00
A
24727
D
Class A Common Stock
2020-12-03
4
A
0
10830
0.00
A
35557
D
The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in three equal installments on the first three
anniversaries of the date of grant.
The restricted stock, granted pursuant to the Director Compensation Policy effective May 2019, vests in full on the date immediately preceding
the date of the annual meeting of stockholders for the next calendar year.
/s/ Conor Kilroy, Attorney-in-Fact
2020-12-03